Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 80701-80750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05664737
A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia
PHASE2Recruiting
249 participants
Started: Dec 9, 2022 · Completed: Aug 14, 2034
1 condition1 sponsor36 locations
NCT05263583
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
PHASE2Active, not recruiting
14 participants
Started: Dec 9, 2022 · Completed: Jun 30, 2025
9 conditions1 sponsor11 locations
NCT05760287
Echocardiographic Characterization of Cardiac Amyloidosis
N/ARecruiting
255 participants
Started: Dec 9, 2022 · Completed: Feb 2, 2031
1 condition1 sponsor1 location
NCT05248802
DLBS2411 Treatment For Functional Dyspepsia
PHASE3Recruiting
106 participants
Started: Dec 9, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor8 locations
NCT05646680
A Performance Study of (opportunistic) Salpingectomy
NARecruiting
200 participants
Started: Dec 9, 2022 · Completed: Jan 30, 2026
2 conditions1 sponsor1 location
NCT06297512
Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
PHASE2Recruiting
20 participants
Started: Dec 9, 2022 · Completed: Mar 9, 2028
1 condition1 sponsor1 location
NCT07042191
A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
NARecruiting
20 participants
Started: Dec 9, 2022 · Completed: May 31, 2027
2 conditions1 sponsor1 location
NCT05657873
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
PHASE2Recruiting
68 participants
Started: Dec 9, 2022 · Completed: Dec 9, 2025
5 conditions1 sponsor9 locations
NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
PHASE3Recruiting
100 participants
Started: Dec 9, 2022 · Completed: Sep 10, 2028
2 conditions1 sponsor60 locations
NCT05634785
CD30 CAR for CD30+ NSGCT
PHASE2Recruiting
18 participants
Started: Dec 9, 2022 · Completed: Aug 31, 2030
2 conditions1 sponsor1 location
NCT05529641
Effects of Diaphragmatic Resistance Training in People with Chronic Neck Pain.
NARecruiting
60 participants
Started: Dec 9, 2022 · Completed: Feb 28, 2025
4 conditions2 sponsors1 location
NCT05537454
Maternal Stress, Milk Composition, and Preterm Neurodevelopment
N/ARecruiting
120 participants
Started: Dec 9, 2022 · Completed: Jul 31, 2030
1 condition1 sponsor1 location
NCT05434117
Feasibility of High-Intensity Interval Nordic Walking in Patients With Coronary Artery Disease
NARecruiting
40 participants
Started: Dec 9, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05675332
Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
NARecruiting
280 participants
Started: Dec 9, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05394168
A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors
PHASE1Active, not recruiting
12 participants
Started: Dec 9, 2022 · Completed: Mar 4, 2025
1 condition1 sponsor1 location
NCT05630612
ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
PHASE2Active, not recruiting
32 participants
Started: Dec 8, 2022 · Completed: Sep 1, 2027
3 conditions2 sponsors1 location
NCT05638854
A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis
PHASE1Recruiting
72 participants
Started: Dec 8, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor2 locations
NCT05513508
The ROTAtional-USE of Interface STUDY
NARecruiting
478 participants
Started: Dec 8, 2022 · Completed: Sep 30, 2028
3 conditions2 sponsors1 location
NCT05546242
Improving HIV-1 Control in Africa with Long Acting Antiretrovirals
PHASE3Active, not recruiting
540 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors7 locations
NCT05487391
A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
PHASE3Recruiting
632 participants
Started: Dec 8, 2022 · Completed: May 22, 2029
1 condition1 sponsor1 location
NCT06209606
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
EARLY_PHASE1Recruiting
30 participants
Started: Dec 8, 2022 · Completed: Feb 28, 2029
1 condition2 sponsors1 location
NCT05610163
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation
PHASE2Active, not recruiting
783 participants
Started: Dec 8, 2022 · Completed: Sep 30, 2033
3 conditions2 sponsors685 locations
NCT05334940
Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases
N/ARecruiting
600 participants
Started: Dec 8, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05515536
A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
PHASE3Active, not recruiting
130 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor14 locations
NCT05938478
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
N/ARecruiting
900 participants
Started: Dec 8, 2022 · Completed: Sep 30, 2035
2 conditions3 sponsors1 location
NCT07111884
GMMG Multiple Myeloma Registry
N/ARecruiting
999 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2027
1 condition4 sponsors35 locations
NCT05090033
Characterizing the Use of Ofatumumab in a Real World Setting
N/AActive, not recruiting
103 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT05668585
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
PHASE1Active, not recruiting
89 participants
Started: Dec 8, 2022 · Completed: Apr 11, 2027
5 conditions1 sponsor26 locations
NCT05559489
Enteral Resuscitation Nepal
PHASE3Recruiting
240 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05650190
Spectacle Lens Visual Acuity Assessments Study
NAActive, not recruiting
51 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor6 locations
NCT05501886
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
PHASE3Recruiting
701 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor217 locations
NCT06847854
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)
PHASE1Recruiting
176 participants
Started: Dec 8, 2022 · Completed: May 30, 2027
1 condition1 sponsor35 locations
NCT05492513
Constraint-Induced Movement Therapy for Adults Post-Stroke With Mild Upper Extremity Impairment
NARecruiting
12 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor1 location
NCT05792631
A Study to Compare Caries Detection in the Pediatric Population Between the iTero Element 5D System and Bitewing Radiographs
NARecruiting
70 participants
Started: Dec 8, 2022 · Completed: Jun 1, 2024
2 conditions1 sponsor1 location
NCT05650619
Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
N/ARecruiting
300 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT05154669
Integrating Financial Coaching and Smoking Cessation Coaching
PHASE3Recruiting
488 participants
Started: Dec 8, 2022 · Completed: Dec 1, 2027
1 condition2 sponsors1 location
NCT05827796
IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer
PHASE1/PHASE2Recruiting
70 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05701150
AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT
N/ARecruiting
3,000 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2025
1 condition4 sponsors3 locations
NCT05432583
A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions
PHASE1Active, not recruiting
318 participants
Started: Dec 8, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor6 locations
NCT05683002
Aronia, Cognition, and Eye Health (ACE)
NARecruiting
44 participants
Started: Dec 8, 2022 · Completed: Aug 31, 2024
1 condition2 sponsors1 location
NCT05647161
BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open Heart Surgery (Japan Trial)
NAActive, not recruiting
34 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor6 locations
NCT05652348
Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer
N/ARecruiting
48 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2028
3 conditions2 sponsors2 locations
NCT05359211
NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
PHASE1Active, not recruiting
28 participants
Started: Dec 8, 2022 · Completed: Sep 4, 2026
9 conditions2 sponsors1 location
NCT04589819
Fracture Recovery for Returning to Duty (Teriparatide STRONG)
PHASE4Enrolling by invitation
183 participants
Started: Dec 8, 2022 · Completed: Dec 30, 2026
1 condition4 sponsors1 location
NCT05658081
Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
NARecruiting
236 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT05112926
Effectiveness and Safety of Embosphere Microspheres for Embolization of the Geniculate Artery for the Treatment of Pain With Known Moderate to Severe Knee Osteoarthritis
NARecruiting
16 participants
Started: Dec 8, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05266664
Preterm Immune System Development and Response to Immunization
N/ARecruiting
145 participants
Started: Dec 8, 2022 · Completed: Jul 31, 2026
3 conditions12 sponsors7 locations
NCT04756401
Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma
PHASE2Active, not recruiting
52 participants
Started: Dec 8, 2022 · Completed: Dec 30, 2027
2 conditions2 sponsors4 locations
NCT05596799
Facing Eating Disorder Fears for Anorexia Nervosa
NARecruiting
70 participants
Started: Dec 8, 2022 · Completed: Aug 1, 2025
3 conditions2 sponsors1 location
NCT05280132
Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial
NARecruiting
204 participants
Started: Dec 8, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location